Stock SBFM SUNE BIOP
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SUNE BIOP OTC Markets

Equities

SBFM

US8677812054

Delayed OTC Markets
Other stock markets
 16:15:16 05/10/2021 BST 		5-day change 1st Jan Change
0.1175 USD -1.26% Intraday chart for SUNE BIOP +0.34% +657.96%
05-13 Certain Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-MAY-2024. CI
04-19 Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product MT

Evolution of the average Target Price on SUNE BIOP

Price target over the last 5 years

History of analyst recommendation changes

9bc5dd698cd07.bMKIs_a10u9avF4PlmYT4oqY2vTJB6x9rXTd_pLuFEk.Ha_6hs_vgLgA_jpbpBFSpuHrqZ6waoEunjnrz_CkJys_p9jhs4ybqgLZEw~3746eb2a1ed100a8000c81b8563529be

Analyst Recommendations on SUNE BIOP

Aegis Capital Initiates Sunshine Biopharma at Buy Rating With $2.60 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8995 USD
Average target price
15 USD
Spread / Average Target
+1,567.59%
High Price Target
15 USD
Spread / Highest target
+1,567.59%
Low Price Target
15 USD
Spread / Lowest Target
+1,567.59%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SUNE BIOP

Aegis Capital

Ratings for SUNE BIOP

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SBFM Stock
  4. SBFM Stock
  5. Consensus SUNE BIOP